Basic Information
| RNALocate ID: | RLID-D:11003981 |
| RNA Symbol: | hsa-miR-506-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-506-3p |
| RNA ID: | miRBase:MIMAT0002878 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003135 | Exosome | Brain tissue | 23382797 |
| RLID:11003136 | Extracellular Vesicle | Plasma | 28588009 |
| RLID-D:11001305 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-506-3p | Ovarian clear cell carcinoma | MNDR-E-MI-56063 |
| MNDR | hsa-miR-506-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-56064 |
| MNDR | hsa-miR-506-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-56065 |
| MNDR | hsa-miR-506-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-56066 |
| MNDR | hsa-miR-506-3p | Her2-receptor positive breast cancer | MNDR-E-MI-56067 |
| MNDR | hsa-miR-506-3p | Lung cancer | MNDR-E-MI-56068 |
| MNDR | hsa-miR-506-3p | Parkinson disease | MNDR-E-MI-56069 |
| MNDR | hsa-miR-506-3p | Breast cancer | MNDR-E-MI-56070 |
| MNDR | hsa-miR-506-3p | Pituitary neoplasms | MNDR-E-MI-56071 |
| MNDR | hsa-miR-506-3p | Pancreatic cancer | MNDR-E-MI-56072 |
| MNDR | hsa-miR-506-3p | Melanoma | MNDR-E-MI-56073 |
| MNDR | hsa-miR-506-3p | Nephroblastoma | MNDR-E-MI-56074 |
| MNDR | hsa-miR-506-3p | Colon cancer | MNDR-E-MI-56075 |
| MNDR | hsa-miR-506-3p | Familial ovarian cancer | MNDR-E-MI-56076 |
| MNDR | hsa-miR-506-3p | Glioma | MNDR-E-MI-56077 |
| MNDR | hsa-miR-506-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-56078 |
| MNDR | hsa-miR-506-3p | Osteosarcoma | MNDR-E-MI-56079 |
| MNDR | hsa-miR-506-3p | Pituitary adenoma | MNDR-E-MI-56080 |
| MNDR | hsa-miR-506-3p | Thyroid carcinoma | MNDR-E-MI-56081 |
| MNDR | hsa-miR-506-3p | Ovarian carcinoma | MNDR-E-MI-56082 |
| MNDR | hsa-miR-506-3p | Pancreatic adenocarcinoma | MNDR-E-MI-56083 |
| MNDR | hsa-miR-506-3p | Kidney chromophobe | MNDR-E-MI-56084 |
| MNDR | hsa-miR-506-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-56085 |
| MNDR | hsa-miR-506-3p | Clear cell renal cell carcinoma | MNDR-E-MI-56086 |
| MNDR | hsa-miR-506-3p | Esophageal cancer | MNDR-E-MI-56087 |
| MNDR | hsa-miR-506-3p | Familiar ovarian carcinoma | MNDR-E-MI-56088 |
| MNDR | hsa-miR-506-3p | Malignant pleural mesothelioma | MNDR-E-MI-56089 |
| MNDR | hsa-miR-506-3p | Retinoblastoma | MNDR-E-MI-56090 |
| MNDR | hsa-miR-506-3p | Skin cutaneous melanoma | MNDR-E-MI-56091 |
| MNDR | hsa-miR-506-3p | Skin melanoma | MNDR-E-MI-56092 |
| MNDR | hsa-miR-506-3p | Nasopharyngeal cancer | MNDR-E-MI-56093 |
| MNDR | hsa-miR-506-3p | Stroke lacunar | MNDR-E-MI-56094 |
| MNDR | hsa-miR-506-3p | Breast cancer her3+ negative | MNDR-E-MI-56095 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CD151 | Homo sapiens | RR00299005 |
TOP